Management of Acute Intracerebral Hemorrhage

Vinall, Phil
March 2010
MD Conference Express;Mar2010, p29
Academic Journal
The article focuses on the proper management of intracerebral hemorrhage (ICH). Doctor Craig Anderson notes that ICH patients must be administered according to the timeline of events and an early computerized tomography (CT) scan for diagnostic assessment is critical. Doctor Joseph P. Broderick uses clinical trials data in ICH to determine the problem associated with the surgical management of ICH such as the role of the location of the ICH in the surgical decision. Doctor J. Claude Hemphill III says that prognostication is important and other care limitations and short of actual withdrawal of medical support may affect the outcome. Doctor Steven M. Greenberg examines the tools and procedures for recovery and prevention of ICH recurrence.


Related Articles

  • Estimation and external validation of a new prognostic model for predicting recurrence-free survival for early breast cancer patients in the UK. Campbell, H. E.; Gray, A. M.; Harris, A. L.; Briggs, A. H.; Taylor, M. A. // British Journal of Cancer;9/7/2010, Vol. 103 Issue 6, p776 

    Background: We aimed to estimate and externally validate a new UK-specific prognostic model for predicting the long-term risk of a first recurrent event (local recurrence, metastatic recurrence, or second primary breast cancer) in women diagnosed with early breast...

  • Warfarin-associated intracerebral hemorrhage. Cavallini, Anna; Fanucchi, Simona; Persico, Alessandra // Neurological Sciences;Sep2008 Supplement 2, Vol. 29, p266 

    Intracerebral hemorrhage (ICH) is the most serious complication of oral anticoagulant therapy (OAT), with mortality in excess of 50%. Major risk factors are advanced patient age, elevated systolic blood pressure, intensity of anticoagulation, and previous cerebral ischemia. A number of acute...

  • Efficacy of Deferoxamine in Animal Models of Intracerebral Hemorrhage: A Systematic Review and Stratified Meta-Analysis. Cui, Han-Jin; He, Hao-yu; Yang, A-Li; Zhou, Hua-Jun; Wang, Cong; Luo, Jie-Kun; Lin, Yuan; Tang, Tao // PLoS ONE;May2015, Vol. 10 Issue 5, p1 

    Intracerebral hemorrhage (ICH) is a subtype of stroke associated with high morbidity and mortality rates. No proven treatments are available for this condition. Iron-mediated free radical injury is associated with secondary damage following ICH. Deferoxamine (DFX), a ferric-iron chelator, is a...

  • DIFFERENTIATED SURGICAL TREATMENT OF PATIENTS WITH HYPERTENSIVE INTRACEREBRAL HEMATOMAS. Agzamov, Mansur; Agzamov, Istam; Bersnev, Valery; Ivanova, Natalia // Medical & Health Science Journal;Aug2011, Vol. 6 Issue 2, p94 

    Hypertensive intracerebral hematoma is one of the most severe forms of cerebrovascular pathology, characterized by high lethality and disability. One of the objectives in providing assistance remains the development of new minimally invasive methods for the removal of hematomas. We have analyzed...

  • Soy and Breast Cancer: Harmful or Helpful? Kiefer, David // Integrative Medicine Alert;Dec2012, Vol. 15 Issue 12, p137 

    The article offers a look at clinical trials that explored the safety of soy supplementation in breast cancer. Information on the mechanism of action of soy isoflavones is provided. Key considerations in these trials are duration of the trial, the dose and source of soy, and demographics being...

  • Quantitative assessment of lymph vascular space invasion (LVSI) provides important prognostic information in node-negative breast cancer. Dekker, T. J. A.; van de Velde, C. J. H.; van Bruggen, D.; Mesker, W. E.; van der Hoeven, J. J. M.; Kroep, J. R.; Tollenaar, R. A. E. M.; Smit, V. T. H. B. M. // Annals of Oncology;Dec2013, Vol. 24 Issue 12, p2994 

    Background Some studies investigating the prognostic value of lymph vascular space invasion (LVSI) have shown an association between LVSI and disease-free survival. Definitive criteria and optimal determination of this parameter remain unclear, however, especially regarding the clinical...

  • Blood Test Stops Cancer Return. TIE, JEANNE; LEE, BELINDA; GIBBS, PETER // Australasian Science;Nov2015, Vol. 36 Issue 9, p29 

    The article focuses on the use of blood circulating tumour (ctDNA) test to predict the risk of cancer recurrence. Topics discussed include a study by the group at the Walter and Eliza Hall Institute of Medical Research which examined the value of ctDNA presence after curative surgery for stage...

  • PREDICTION OF SURVIVAL IN PULMONARY ARTERIAL HYPERTENSION USING SURVIVAL EQUATIONS. RESULTS FROM THE PULMONARY HYPERTENSION REGISTRY OF THE UK AND IRELAND. Ling, Y.; Johnson, M. K.; Kiely, D.; Condliffe, R.; Elliot, C.; Gibbs, S.; Howard, L.; Pepke-Zaba, J.; Sheares, K.; Corris, P.; Fisher, A.; Lordan, J.; Gaine, S.; Coghlan, G.; Wort, J.; Gatzoulis, M.; Peacock, A. J. // Thorax;Dec2011 Supplement, pA35 

    Introduction The NIH survival equation was developed in the 1980s and used in many clinical trials to show survival benefit. Since then, significant advances had been made in the diagnosis and management of pulmonary arterial hypertension (PAH). Several new equations have been developed to...

  • Circulating tumor cells in HER2-positive metastatic breast cancer patients: a valuable prognostic and predictive biomarker. Yi Liu; Qian Liu; Tao Wang; Li Bian; Shaohua Zhang; Haixu Hu; Sha Li; Zhiyuan Hu; Shikai Wu; Bing Liu; Zefei Jiang // BMC Cancer;2013, Vol. 13 Issue 1, p1 

    Background: This study was initiated to investigate the prognostic significance of circulating tumor cell (CTC) enumeration and the predictive value of CTC HER2 expression for efficient anti-HER2 therapy in HER2-positive metastatic breast cancer (MBC) patients. Methods: Sixty HER2-positive MBC...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics